Neurogenic Rosacea: A Distinct Clinical Subtype Requiring a Modified Approach to Treatment

The document discusses two separate studies. The first study examined the prevalence of iron deficiency (ID) in Caucasian women with female pattern hair loss (FPHL) or chronic telogen effluvium (CTE) compared to control subjects without hair loss. The study included 381 women with FPHL or CTE and 76 control subjects. It found that ID was common among women but did not occur at a higher rate in those with FPHL or CTE compared to controls. The study noted limitations such as the lack of diversity in the sample and the unknown effects of iron correction on hair loss, suggesting the need for future research. The second study described in the document focused on a potential distinct clinical subtype of rosacea, termed neurogenic rosacea, which was identified in 14 patients exhibiting classic rosacea symptoms along with prominent neurological symptoms. The study found that 43% of these patients had neurological conditions and 50% had neuropsychiatric conditions. Various treatments, including neurologically focused treatments and traditional therapies, provided relief. The authors concluded that neurogenic rosacea may require a modified treatment approach, emphasizing the need for a diagnostic and treatment algorithm for this subtype.